Primary Site >> Liver Cancer
Gene >> CYP2C8
| 1. | |||||||||||
| Journal: | Curr Drug Metab. 2004 Jun;5(3):211-24. | ||||||||||
| Title: | Cytochrome P450 gene polymorphism and cancer. | ||||||||||
| Author: | Agundez, Jose A G | ||||||||||
| PMID: | 15180491 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncotarget. 2016 Aug 2;7(31):50612-50623. | ||||||||||
| Title: | Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. | ||||||||||
| Author: | Zhou, Jun|Wen, Qiang|Li, Sai-Fei|Zhang, Yun-Fei|Gao, Na|Tian, Xin|Fang, Yan|Gao, Jie|Cui, Ming-Zhu|He, Xiao-Pei|Jia, Lin-Jing|Jin, Han|Qiao, Hai-Ling | ||||||||||
| PMID: | 27203676 | ||||||||||
| 3. | |||||||||||
| Journal: | Can J Physiol Pharmacol. 2017 Jun;95(6):768-771. | ||||||||||
| Title: | Downregulation of cytochrome P450 2C8 by 3-methylcholanthrene in human hepatocellular carcinoma cell lines. | ||||||||||
| Author: | Utgikar, Rucha|Riddick, David S | ||||||||||
| PMID: | 28384415 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Med. 2018 Apr;7(4):966-980. | ||||||||||
| Title: | The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma. | ||||||||||
| Author: | Wang, Xiangkun|Yu, Tingdong|Liao, Xiwen|Yang, Chengkun|Han, Chuangye|Zhu, Guangzhi|Huang, Ketuan|Yu, Long|Qin, Wei|Su, Hao|Liu, Xiaoguang|Peng, Tao | ||||||||||
| PMID: | 29479826 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2018 Apr 24;9(31):22058-22068. | ||||||||||
| Title: | The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. | ||||||||||
| Author: | Ashida, Ryo|Okamura, Yukiyasu|Ohshima, Keiichi|Kakuda, Yuko|Uesaka, Katsuhiko|Sugiura, Teiichi|Ito, Takaaki|Yamamoto, Yusuke|Sugino, Takashi|Urakami, Kenichi|Kusuhara, Masatoshi|Yamaguchi, Ken | ||||||||||
| PMID: | 29774122 | ||||||||||
| 6. | |||||||||||
| Journal: | Biomed Res Int. 2018 Jul 25;2018:5859415. | ||||||||||
| Title: | Downregulation of CYP2A6 and CYP2C8 in Tumor Tissues Is Linked to Worse Overall Survival and Recurrence-Free Survival from Hepatocellular Carcinoma. | ||||||||||
| Author: | Ren, Xiaojing|Ji, Yuanyuan|Jiang, Xuhua|Qi, Xun | ||||||||||
| PMID: | 30148168 | ||||||||||